CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- 4 Grant or award Director acquired 8,829 shares (grant or award)
- 4 Grant or award Director acquired 8,829 shares (grant or award)
- 4 Grant or award Director acquired 8,829 shares (grant or award)
- 4 Grant or award Director acquired 8,829 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 28,893 shares at an average $24.54 ($709,057)
- 4 Open-market sale Hindson Benjamin J. sold 11,595 shares at $24.44 ($283,399)
- 4 Open-market sale Chief Financial Officer sold 15,098 shares at $24.44 ($369,018)
- 4 Planned sale Chief Executive Officer sold 5,000 shares at $24.56 ($122,784)
- 4 Planned sale Chief Executive Officer sold 15,000 shares at an average $19.26 ($288,909)
- 4 Planned sale Chief Executive Officer sold 16,152 shares at an average $22.73 ($367,097)
- 4 Grant or award Chief Executive Officer acquired 157,895 shares (grant or award)
- 4 Grant or award Hindson Benjamin J. acquired 88,816 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 106,579 shares (grant or award)
- 4 Planned sale Director sold 7,579 shares at $19.41 ($147,108)
- 4 Open-market sale Chief Executive Officer sold 9,632 shares at $18.58 ($178,928)
- 4 Open-market sale Chief Financial Officer sold 8,968 shares at $18.58 ($166,593)
- 4 Open-market sale Hindson Benjamin J. sold 7,826 shares at $18.58 ($145,379)
- 4 Exercise or conversion Chief Executive Officer acquired 50,000 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 11,888 shares at $19.00 ($225,852)
- 4 Open-market sale Hindson Benjamin J. sold 8,283 shares at $19.00 ($157,363)
Page 2 of 21 · 410 filings